If you have been following our previous posts; Engineers to develop spectacle lenses for keratoconus patients, Research update and Spectacles for KC Research update 2, you will be aware of Dr Ahmed’s work to address the problem of non-orthogonal astigmatism.
At our AGM and Speaker meeting both Dr Abass and optometrist Lynn White, carefully explained the progress of their work to find a solution for those of us who have to cope with not wearing contact lenses for a period of time; yet still need better vision for dealing with basic tasks. Both Ahmed and Lynn are convinced that with the advance of technology, spectacles can be manufactured to take account of a non-orthogonal angle of astigmatism. Indeed, some who have worn the spectacles in laboratory conditions, do not want to give them back.
In this clip, Dr Abass explained how he was able to interpret the high-resolution results without relying on the software provided by modern topography machines. He noticed that astigmatism is not always orthogonal, which led to his research project to find a better solution for keratoconus.
Here Lynn White explains the wider implications of Dr Abass’ research beyond keratoconus.
There is still a long way to go but results to date are promising. More details will be given in our next newsletter.
Here is the press release from Liverpool University.
In a recent KC patient group meeting, Dr Ahmed Abass from the University of Liverpool unveiled exciting research into a new type of spectacle lens designed to help those living with keratoconus; a progressive eye condition that causes thinning and irregular shaping of the cornea.
Traditional glasses often fall short in correcting vision for keratoconus patients due to a phenomenon called non-orthogonal astigmatism. However, Dr Abass and his team, supported by Fight for Sight and the UK Keratoconus Self-Help and Support Association, have been exploring an innovative lens design that targets this issue directly.
The results are encouraging. In this pilot study, many participants experienced clearer vision, reduced ghosting, and sharper letter recognition with these specially designed lenses.
“This is the first study of its kind,” Dr Abass said. “We’ve shown that the idea works. Now we need to focus on scaling it up, finding ways to mass produce these lenses and test them on a larger group.”
As the project looks towards the next stage, development and commercialisation, there may be exciting opportunities for those in the optical or medical device industries to get involved. Anyone interested in collaborating with the University of Liverpool or learning more is welcome to contact Dr Abass at a.abass@liverpool.ac.uk. or connect via linkedin
It is a small but meaningful step forward, offering new possibilities for those seeking alternatives to contact lenses or invasive procedures.
https://www.liverpool.ac.uk/people/ahmed-abass